ARCA biopharma initiates randomisation of first European patients in GENETIC-AF Phase 2B/3 trial

ARCA biopharma has announced the randomisation of the first European patients in the GENETIC-AF Phase 2B/3 clinical trial.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals